| Company name | Ticker | Asset type | Sector | Market cap | % in ETF |
|---|---|---|---|---|---|
| ISRG | Stock | Healthcare | US$ 131.38 B | 11,50% | |
| SYK | Stock | Healthcare | US$ 118.14 B | 10,04% | |
| EW | Stock | Healthcare | US$ 51.76 B | 10,01% | |
| MDT | Stock | Healthcare | US$ 120.46 B | 9,53% | |
| DXCM | Stock | Healthcare | US$ 33.17 B | 7,56% | |
Sonova H Ag
|
SOON | Stock | Healthcare | US$ 14.76 B | 4,81% |
Straumann Holding AG
|
STMN | Stock | Healthcare | US$ 14.32 B | 4,46% |
| ZBH | Stock | Healthcare | US$ 18.87 B | 3,99% | |
| SNN | Stock | Healthcare | US$ 11.06 B | 3,52% | |
| GMED | Stock | Healthcare | US$ 10.15 B | 3,17% | |
| PODD | Stock | Healthcare | US$ 10.23 B | 3,17% | |
Glaukos Corp
|
GKOS | Stock | Healthcare | US$ 9.66 B | 3,05% |
Cochlear Ltd
|
COH | Stock | Healthcare | US$ 8.20 B | 2,60% |
Integer Holdings Corp
|
ITGR | Stock | Healthcare | US$ 4.30 B | 2,43% |
| AMP | Stock | Healthcare | US$ 49.92 B | 2,26% | |
| ATEC | Stock | Healthcare | US$ 1.54 B | 2,25% | |
Inspire Medical Systems Inc
|
INSP | Stock | Healthcare | US$ 2.02 B | 2,15% |
Envista Holdings Corp
|
NVST | Stock | Healthcare | US$ 3.77 B | 2,06% |
| LMAT | Stock | Healthcare | US$ 1.81 B | 2,05% | |
| TMDX | Stock | Healthcare | US$ 2.77 B | 2,03% | |
| AXGN | Stock | Healthcare | US$ 2.19 B | 1,86% | |
|
Demant A/S
|
WDH | Stock | Other | US$ 370.08 M | 1,85% |
Artivion Inc
|
AORT | Stock | Healthcare | US$ 1.09 B | 1,70% |
Procept Biorobotics Corp
|
PRCT | Stock | Healthcare | US$ 982.82 M | 1,60% |
LifeTech Scientific Corp
|
1302 | Stock | Healthcare | US$ 6.10 B | 0,72% |
Average Investor10 user rating
4.0
(0 people)
VanEck Bionic Engineering UCITS ETF A Acc (Ireland) is an exchange-traded fund (ETF), with assets under management totaling $4.75 million.
Over the past 12 months, VanEck Bionic Engineering UCITS ETF A Acc recorded a return of -10.75%, with its price trading between $0.00 and $21.82 during the same period.
The ETF is traded under the ticker CYBO.
The current price of CYBO is $18.63. You can track the real-time price chart, review historical performance, and access detailed information about this ETF on the platform.
CYBO is currently trading at $18.63, with a market capitalization of approximately $4.750.000,00. Over the past year, the ETF has delivered a -10.75% return, based on share price performance.
Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.
You can invest in CYBO through a brokerage account that provides access to the exchange where it is listed. After opening and funding your account, search for the ticker symbol CYBO, select the number of shares you wish to purchase, and place your order.
In certain markets, similar exposure may also be available through locally listed products that track the same index.
Over the past month, CYBO has returned -2.04%, and -10.75% over the past year.
If you were to purchase 100 shares of CYBO at the current price of $18.63, your total investment would be $1,863.00.
Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.
Sign in with your social account or email
Create your account
Already have an account? Login
Tesla
Dividend Schedule
Ranking of Stocks
Ranking of Brazilian ETFs
Crypto Rankings
